Issues related to the development, manufacture, and distribution of coronavirus vaccines;
H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis;
H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose;
Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis;
Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use;
S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies;
Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone;
Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding  for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government. Issues related to the development, manufacture, and distribution of coronavirus vaccines;
H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis;
H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose;
Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis;
Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use;
S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies;
Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone;
Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding  for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government. H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis;
H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose;
Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis;
Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use;
S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies;
Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone;
Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding  for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government. Issues related to the development, manufacture, and distribution of coronavirus vaccines;
H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose;
H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis;
Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use;
S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies;
Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone;
Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding  for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
DIS - Disaster Planning/Emergencies HCR - Health Issues BUD - Budget/Appropriations HOM - Homeland Security
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC
701 EIGHTH STREET, NW, SUITE 610, WASHINGTON, DC, 20001, US
TIMOTHY P HECHT FRANKLIN C PHIFER THOMAS PAUL LATHAM TIMOTHY P HECHT FRANKLIN C PHIFER THOMAS PAUL LATHAM TIMOTHY P HECHT FRANKLIN C PHIFER THOMAS PAUL LATHAM TIMOTHY P HECHT FRANKLIN C PHIFER THOMAS PAUL LATHAM